Key result
The A-20C mutation in the human angiotensinogen gene showed a weak but significant correlation with plasma AGT concentrations and essential hypertension.
Why the study?
Is the A-20C mutation in the human AGT gene associated with increased plasma AGT concentrations and essential hypertension?
Cross-Sectional
Is the A-20C mutation in the human AGT gene associated with increased plasma AGT concentrations and essential hypertension?
Answers are grounded in this paper and cite their sources.
The A-20C mutation in the human AGT gene promoter region is weakly but significantly associated with elevated plasma AGT concentrations and essential hypertension.
The angiotensinogen (AGT) gene M235T variant is associated with essential hypertension and elevated plasma AGT concentrations, although the underlying mechanisms are unknown. Recent studies have suggested that AGCE 1 (human AGT gene core promoter element 1) located in the 5' upstream core promoter region (position -25 to -1) of the human AGT gene has an important part in the expression of AGT mRNA by binding with transcription factor AGCF 1 (human AGT gene core promoter element binding factor 1), and a mutation at -20 from adenine to cytosine (A-20C) increases the level of expression of this transcript. We therefore examined subjects with this mutation to study the association with increased plasma AGT concentrations and with essential hypertension. One hundred eighty-eight subjects receiving no antihypertensive medication were examined with regard to the correlation between A-20C and plasma AGT concentrations, and 234 subjects were studied with respect to the association between A-20C and essential hypertension. A-20C was determined by polymerase chain reaction-restriction fragment length polymorphism analysis with EcoOR 109I. Multiple regression analysis showed a weak but significant correlation between A-20C and plasma AGT concentrations (P=.047) and essential hypertension (P=.049). The results suggest that A-20C may underlie the increase in plasma AGT concentrations and be involved in the development of essential hypertension.
No takes yet. Share an insight, caveat, or question.
Ishigami et al. (1997) conducted a cross-sectional in Essential hypertension. A-20C mutation in the human angiotensinogen gene vs. Absence of A-20C mutation was evaluated on Correlation with plasma AGT concentrations and essential hypertension (p=0.047 (AGT), 0.049 (hypertension)). The A-20C mutation in the human angiotensinogen gene showed a weak but significant correlation with plasma AGT concentrations and essential hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: